搜索筛选:
搜索耗时4.7105秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
类      型:
[期刊论文] 作者:Mengxin Tian,Yinghong Shi,Weir, 来源:中国科学:生命科学英文版 年份:2019
Hepatocellular carcinoma(HCC) is the most frequent primary liver cancer,leading to 74.6 thousand deaths annually.The prognosis of HCC over the last few decades...
[期刊论文] 作者:Qiang Gao,Yinghong Shi,Xiaoying Wang,Jian Zhou,Shuangjian Qiu,Jia Fan, 来源:医学前沿 年份:2012
Hepatocellular carcinoma (HCC) is a highly complex disease that is generally resistant to commonly used chemotherapy and radiotherapy.Consequently,there is an u...
[会议论文] 作者:Yuli Lin,Xuguang Yang,Weiren Liu,Bingji Li,Wei Yin,Yinghong Shi,Rui He, 来源:The 1st NI-CMI Joint Conference(第一届CMI-NI免疫学国际研讨会) 年份:2015
[会议论文] 作者:Yuli Lin,Xuguang Yang,Weiren Liu,Bingji Li,Wei Yin,Yinghong Shi,Rui He, 来源:The 1st NI-CMI Joint Conference(第一届CMI-NI免疫学国际研讨会) 年份:2015
Chemerin is highly expressed in hepatocytes, and recently suggested to regulate tissue inflammation.Hepatocellular carcinoma (HCC) is associated with Inflammation and immunosuppression, which is chara...
相关搜索: